Click Here To Print
Product Detail
ebc item NOTICE: This is the ProQuest Ebook Central� format of this title. What is ProQuest Ebook Central�?
Other formats: Hardcover All Formats

Targeted Cancer Immune Therapy

Lustgarten, Joseph
Targeted Cancer Immune Therapy Cover Image
Pricing & Availability
Available: Yes*
This title does not qualify for any discount.


Other formats:
Book Information
Edition: 1st
Publisher: Springer Nature
ISBN: 1-4419-0170-1 (1441901701)
ISBN-13: 978-1-4419-0170-5 (9781441901705)
Binding: E E Book + ProQuest Ebook Central
Copyright: 2009
Publish Date: 10/09
Weight: 0.00 Lbs.
Subject Class: ONC (Oncology)
Return Policy: Non-Returnable.
Table Of Contents: View
   
ProQuest Ebook Central�: eBook Please sign in to preview this title
 
Class Specifications
Discipline: Pathology
Subject Definition: Neoplasms-Therapy; Immunotherapy
NLM Class: QZ 266
LC Class: RC271
Abstract: The principle of cancer immune therapy remains the stimulation of the immune system to control and destroy tumors, but the scope is expanded in steady and fast pace, the approach is modernized every few years, new molecules are revealed annually, and the understanding of the mechanisms is getting deeper and deeper. Targeted Cancer Immune Therapy covers cytokine immune therapy, cell-based immune therapy, and targeted immune therapy. In each of these three sections, only the novel aspects of immune therapy were selectively described instead of attempting to cover any historical achievement. In the first section, Cytokine Immune Therapy, the IL12 family, IL18, IL21, IL24, IL28, and IL29 were heavily discussed in regard to the anti-tumor function and application in treating tumors. In the second section, Cell-based Immune Therapy, the focus was given to engineering potent immune regulatory or effector cells such as dendritic cells, T cells, and stem cells. The cell engineering design is primarily based on the increased understanding of the interaction of tumor antigen presenting cells, antigen specific effector cells, and the tumor microenvironment. In the third section, Targeted Immune Therapy, the focus was given on rearticulating the antibody therapy for boosting immune response, which includes immunocytokines, "T-body", and tumor targeted CpG ODN. Immunocytokines represent a new class of biopharmaceuticals composed of two well known immune components . antibodies and cytokines . with the unique ability to target cytokines to the tumor microenvironment and thereby activate antitumor responses. Some or all of these innovative approaches may ultimately become the future effective immune therapy for treating malignancy.
* Subject to ProQuest Ebook Central� availability
close

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement